Clinical impact of real‐time androgen receptor alteration monitoring on metastatic castration‐resistant prostate cancer treatment in real‐world settings

Documents similaires

• Impact of proton pump inhibitors on the efficacy of androgen receptor signaling inhibitors in metastatic castration‐resistant prostate cancer patients
  par: Tokiyoshi Tanegashima, et autres
  Publié: (2024)
• S1: List of specimens used for DNA barcoding (with sampling sites and date, sequence length (bp), Sample/Process ID, Genbank accession, Institution).
  par: Pühringer, Franz
  Publié: (2025)
• Reply to Letter to the Editor on “Impact of proton pump inhibitors on the efficacy of androgen receptor signaling inhibitors in metastatic castration‐resistant prostate cancer patients”
  par: Tokiyoshi Tanegashima, et autres
  Publié: (2024)
• Bellmunt risk score as a survival predictor in patients with metastatic castration‐resistant prostate cancer
  par: Thomas Büttner, et autres
  Publié: (2024)
• Current state of theranostics in metastatic castrate‐resistant prostate cancer
  par: Udit Nindra, et autres
  Publié: (2024)